Home / Products /Genome Editing /EGFP Stable Cell Line /Human gastric adenocarcinoma cells (AGS-EGFP)

Human gastric adenocarcinoma cells (AGS-EGFP)

Catalog Number: EC0011

Price:
$1066.67
Specifications Overview Application Downloads Related products

Specifications

Product Information
Product Name Human gastric adenocarcinoma cells (AGS-EGFP)
Specifications 1*10^6
Storage and transportation Dry ice preservation/T25 live cell transportation.
Cell name AGS-EGFP
Cell morphology Epithelioid, adherent cell
Passage ratio 1:2~1:4
species Human
Construction method Virus Method
Mycoplasma testing negative
Cultivation System 90% F12K+10% FBS

Overview

Introducing AGS-EGFP human gastric adenocarcinoma cells uniquely engineered for optimal research and therapeutic applications; these epithelioid adherent cell lines are preserved using dry ice for reliable transportation and storage providing a dynamic platform for exploring cancer biology and advancing oncology research with a negative virus method and high viability in a 90% F12K + 10% FBS culture medium

Application

The Human gastric adenocarcinoma cells (AGS-EGFP) represent a pivotal tool in cancer research particularly for studying the biology of gastric cancer via their unique fluorescent tagging that allows for real-time observation of cellular processes These adherent and epithelioid cells are preserved in dry ice ensuring viability during transportation or storage thus enabling researchers to perform critical experiments in various geographical locations without compromise to the integrity of the samples

In therapeutic development AGS-EGFP cells are essential for screening new anti-cancer drugs providing insights into their efficacy and mechanisms of action against human gastric cancer cells Additionally these cells can be utilized for the investigation of cellular responses to viral infections providing a platform to explore potential treatments for viral-related cancers while maintaining a negative viral history ensuring that observations are solely related to gastric adenocarcinoma

With nutrients provided through a specialized medium of 90% F12K and 10% FBS AGS-EGFP cells thrive during experimentation facilitating in-depth studies into gene expression and signal transduction pathways that drive the progression of cancer Their carefully controlled culture conditions lend themselves to reproducibility in research making AGS-EGFP a reliable resource for both academic and pharmaceutical initiatives focused on combating gastric cancer

Downloads

Please note that all services are for research use only. Not intended for any clinical use.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.